Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Menlo Park, California
- Most recent report
- 8-K, filed Aug 24, 2026
- Incorporated
- Delaware
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 907654
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 72
News 8 of 257
Prospectuses and Registrations 8 of 111
- 424B5 Prospectus supplement for an offering Aug 28, 2026
- S-3 Shelf registration statement Aug 21, 2026
- 424B5 Prospectus supplement for an offering Apr 29, 2026
- 424B5 Prospectus supplement for an offering Apr 27, 2026
- 424B5 Prospectus supplement for an offering Apr 27, 2026
- S-3 Shelf registration statement Apr 2, 2026
- S-8 Registration statement for an employee plan Mar 12, 2026
- 424B3 Prospectus supplement for an offering Nov 5, 2025
Proxies 8 of 41
- DEFA14A Extra proxy material Apr 17, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 17, 2026
- DEFA14A Extra proxy material Apr 18, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 18, 2025
- DEF 14A Proxy statement for a shareholder vote Oct 18, 2024
- PRE 14A Preliminary proxy statement Oct 7, 2024
- DEFA14A Extra proxy material Dec 19, 2023
- DEF 14A Proxy statement for a shareholder vote Dec 19, 2023
Ownership 8 of 420
- 4 Insider reported a trade Sep 21, 2026
- 4 Insider reported a trade Sep 21, 2026
- 144 Notice of a proposed sale of restricted stock Sep 21, 2026
- 4 Insider reported a trade Sep 15, 2026
- 4 Insider reported a trade Sep 15, 2026
- 4 Insider reported a trade Sep 15, 2026
- 4 Insider reported a trade Sep 15, 2026
- 4 Insider reported a trade Sep 15, 2026
Other 8 of 99
- EFFECT Notice that a registration became effective Aug 27, 2026
- 424B7 Apr 21, 2026
- ARS Annual report sent to shareholders Apr 17, 2026
- EFFECT Notice that a registration became effective Apr 10, 2026
- CORRESP Reply to SEC staff Apr 8, 2026
- UPLOAD Comment letter from SEC staff Apr 7, 2026
- ARS Annual report sent to shareholders Apr 18, 2025
- EFFECT Notice that a registration became effective Mar 11, 2025
Everything here comes from Oruka Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.